Literature DB >> 15901669

Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

Karl Swedberg1, John Cleland, Henry Dargie, Helmut Drexler, Ferenc Follath, Michel Komajda, Luigi Tavazzi, Otto A Smiseth, Antonello Gavazzi, Axel Haverich, Arno Hoes, Tiny Jaarsma, Jerzy Korewicki, Samuel Lévy, Cecilia Linde, José-Luis Lopez-Sendon, Markku S Nieminen, Luc Piérard, Willem J Remme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15901669     DOI： 10.1093/eurheartj/ehi204

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  349 in total

Review 1.  Cardiopulmonary exercise test in chronic heart failure: beyond peak oxygen consumption.

Authors:  Veronica Franco
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 2.  Testosterone and heart failure.

Authors:  Maurizio Volterrani; Giuseppe Rosano; Ferdinando Iellamo
Journal:  Endocrine       Date:  2012-06-24       Impact factor: 3.633

3.  The effect of respiratory scoring on the diagnosis and classification of sleep disordered breathing in chronic heart failure.

Authors:  Neil R Ward; Vitor Roldao; Martin R Cowie; Stuart D Rosen; Theresa A McDonagh; Anita K Simonds; Mary J Morrell
Journal:  Sleep       Date:  2013-09-01       Impact factor: 5.849

4.  Views of patients with heart failure about their role in the decision to start implantable cardioverter defibrillator treatment: prescription rather than participation.

Authors:  Anders Agård; Rurik Löfmark; Nils Edvardsson; Inger Ekman
Journal:  J Med Ethics       Date:  2007-09       Impact factor: 2.903

5.  Guideline concordance of testing for hyperkalemia and kidney dysfunction during initiation of mineralocorticoid receptor antagonist therapy in patients with heart failure.

Authors:  Larry A Allen; Susan M Shetterly; Pamela N Peterson; Jerry H Gurwitz; David H Smith; David W Brand; Diane L Fairclough; John S Rumsfeld; Frederick A Masoudi; David J Magid
Journal:  Circ Heart Fail       Date:  2013-11-26       Impact factor: 8.790

6.  Sublingual administration of furosemide: new application of an old drug.

Authors:  Laurent Haegeli; Hans Peter Brunner-La Rocca; Markus Wenk; Matthias Pfisterer; Jürgen Drewe; Stephan Krähenbühl
Journal:  Br J Clin Pharmacol       Date:  2007-09-13       Impact factor: 4.335

7.  Isolated diastolic dysfunction--diagnostic value of tissue Doppler imaging, colour M-mode and N-terminal pro B-type natriuretic peptide.

Authors:  S Hettwer; B Panzner-Grote; R Witthaut; K Werdan
Journal:  Clin Res Cardiol       Date:  2007-09-20       Impact factor: 5.460

8.  Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing.

Authors:  Amy D Bradshaw; Catalin F Baicu; Tyler J Rentz; An O Van Laer; D Dirk Bonnema; Michael R Zile
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

9.  Effects of candesartan cilexetil "add-on" treatment in congestive heart failure outpatients in daily practice.

Authors:  Veselin Mitrovic; Karl-Friedrich Appel; Nicolaos Proskynitopoulos; Seyfettin Dereli; Christian Wilhelm Hamm
Journal:  Clin Res Cardiol       Date:  2009-03-18       Impact factor: 5.460

10.  Cardiac resynchronization therapy evaluated by myocardial scintigraphy with 99mTc-MIBI: changes in left ventricular uptake, dyssynchrony, and function.

Authors:  Simone C S Brandão; Silvana A D Nishioka; Maria C P Giorgi; Ji Chen; Rubens Abe; Martino Martinelli Filho; Viviane T Hotta; Marcelo L Vieira; Ernest V Garcia; José C Meneghetti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-14       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.